首页> 外文期刊>Vaccine >Reactogenicity in the elderly of nine commercial influenza vaccines:results from the Italian SVEVA study
【24h】

Reactogenicity in the elderly of nine commercial influenza vaccines:results from the Italian SVEVA study

机译:九种商业流感疫苗在老年人中的反应原性:意大利SVEVA研究的结果

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A 10-fold increase of reported adverse events following influenza vaccination in the 1995-1996 campaign was reported. To evaluate the relative reactogenicity of different influenza vaccines a prospective observational study was conducted in 72 Italian local health units (LHU) in the period October-December 1996. Of the 16,637 enrolled individuals aged 65 or more, 27.4% reported the occurrence of at least one adverse event within 72 h of vaccination. The odds ratios, adjusted through a multivariate logistic model, were highest for whole vaccine recipients. Most of the observed events were of moderate clinical severity and were mainly represented by local symptoms. None of the products was found to show an unusual or concerning reactogenicity profile, and no severe events associated with immunization were reported.: (C) 1999 Elsevier Science Ltd. All rights reserved. [References: 16]
机译:据报道,在1995-1996年的运动中,接种流感疫苗后报告的不良事件增加了10倍。为了评估不同流感疫苗的相对反应原性,1996年10月至12月在72个意大利地方卫生部门(LHU)进行了一项前瞻性观察研究。在16637名65岁或以上的已登记患者中,至少有27.4%的人发生了这种情况。接种后72小时内发生1次不良事件。通过多元逻辑模型调整的比值比对全疫苗接种者最高。观察到的大多数事件具有中等的临床严重性,主要表现为局部症状。没有发现任何产品显示异常或相关的致反应性,也未报告与免疫相关的严重事件。(C)1999 Elsevier Science Ltd.保留所有权利。 [参考:16]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号